Alan Colman
Directeur/Membre du Conseil chez VOLITIONRX LIMITED
Fortune : 149 768 $ au 30/04/2024
Profil
Alan Colman is currently an Independent Director at VolitionRX Ltd.
and Volition America, Inc. He is also a Director at Gaibian Associates Pte Ltd.
and an Associate at Harvard University.
Previously, he was the Chief Executive Officer at ES Cell International Pte Ltd.
and the Research Director at PPL Therapeutics Plc.
He also served as a Director at Singapore Volition Pte Ltd.
and as the Executive Director at The Singapore Stem Cell Consortium.
Additionally, he was a Professor of Biochemistry at the University of Birmingham and a Professor of Regenerative Medicine at King's College London.
Colman received his undergraduate, graduate, and doctorate degrees from the University of Oxford and a doctorate degree from the University of Cambridge.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VOLITIONRX LIMITED
0,21% | 08/05/2024 | 168 279 ( 0,21% ) | 149 768 $ | 30/04/2024 |
Postes actifs de Alan Colman
| Sociétés | Poste | Début |
|---|---|---|
| VOLITIONRX LIMITED | Directeur/Membre du Conseil | 06/10/2011 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Volition America, Inc.
 Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Directeur/Membre du Conseil | 06/10/2011 |
| Gaibian Associates Pte Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Alan Colman
| Sociétés | Poste | Fin |
|---|---|---|
Singapore Volition Pte Ltd.
 Singapore Volition Pte Ltd. Hospital/Nursing ManagementHealth Services Part of VolitionRX Ltd., Singapore Volition Pte Ltd. provides diagnostic services for cancer patients. Singapore Volition was acquired by Standard Capital Corp. on October 07, 2011 for $0.07 million. | Directeur/Membre du Conseil | 15/12/2015 |
| The Singapore Stem Cell Consortium | Directeur/Membre du Conseil | 01/01/2013 |
| King's College London | Corporate Officer/Principal | 01/01/2009 |
ES Cell International Pte Ltd.
 ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Directeur Général | 01/01/2007 |
PPL Therapeutics Plc
 PPL Therapeutics Plc Pharmaceuticals: MajorHealth Technology PPL Therapeutics Plc produces commercially valuable proteins. It is a multinational corporation operating in the field of recombinant proteins using transgenic technology. The company does business in the pharmaceutical, biotechnology and nutraceutical industries. PPL is headquartered in Edinburgh, UK. | Directeur Technique/Scientifique/R&D | 01/03/2002 |
Formation de Alan Colman
| University of Cambridge | Doctorate Degree |
| University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VOLITIONRX LIMITED | Health Technology |
| Entreprise privées | 6 |
|---|---|
| The Singapore Stem Cell Consortium | |
PPL Therapeutics Plc
PPL Therapeutics Plc Pharmaceuticals: MajorHealth Technology PPL Therapeutics Plc produces commercially valuable proteins. It is a multinational corporation operating in the field of recombinant proteins using transgenic technology. The company does business in the pharmaceutical, biotechnology and nutraceutical industries. PPL is headquartered in Edinburgh, UK. | Health Technology |
ES Cell International Pte Ltd.
ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Health Technology |
Singapore Volition Pte Ltd.
Singapore Volition Pte Ltd. Hospital/Nursing ManagementHealth Services Part of VolitionRX Ltd., Singapore Volition Pte Ltd. provides diagnostic services for cancer patients. Singapore Volition was acquired by Standard Capital Corp. on October 07, 2011 for $0.07 million. | Health Services |
Volition America, Inc.
Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Health Services |
| Gaibian Associates Pte Ltd. |
